A Minnesota-based medical device company with Wisconsin ties recently took a big step toward commercialization.

HistoSonics Inc. earlier this month received approval from the Food and Drug Administration to market its histotripsy platform — a device that destroys cancerous tissue with sound waves.

The company is now moving ahead quickly with the commercialization of its Edison medical device, which is aimed at treating liver tumors without using a scalpel or needles.

Click here to read the full article.